ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 610458 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 610458; 2) Community: the network communities that were significantly associated with the response to NSC 610458; 3) Molecule: the relationships between components within communities and NSC 610458; 4) MDR: the compounds that were significantly associated with the NSC 610458.

NSC Compound Enrichment Correlation
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0209467683758286 0.47595734
NSC 300289 Pinafide 0.0209467683758286 0.69428318
NSC 313681 Oxiperomide(USAN) 0.0209467683758286 0.012703783
NSC 328410 Camptothecin Derivative 0.0209467683758286 0.69649669
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0209467683758286 0.46570532
NSC 619030 Analog of CC-1065 0.0209467683758286 0.65760131
NSC 673652 2-Ethylaminoestradiol 0.0209467683758286 0.09199195
NSC 673787 Null 0.0209467683758286 0.08290851
NSC 674182 Null 0.0209467683758286 0.72693187
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0209467683758286 0.11584152
Total:74  Current:36    [First] [Prev] [Next] [Last]